医疗器械企业归创通桥(02190.HK)于7月15日向香港联合交易所提交翌日披露报表，公告显示该公司在公开市场回购50万股普通股。本次回购交易总额达1,007,565港元，所购股份将作为库藏股予以留存。
根据港交所披露机制，上市公司须在股份回购交易次日提交完整交易记录。此次操作标志着归创通桥年内首次启动股份回购计划，每股回购均价约合2.015港元。库藏股制度允许企业将回购股份用于员工激励计划或资本结构优化，但不可参与股息分配。
二级市场数据显示，归创通桥股价近三个月累计涨幅逾15%，此次回购时点恰逢公司新产品获批上市的关键阶段。分析人士指出，医疗设备企业选择在市场估值低位实施回购，通常传递管理层对业务前景的信心信号。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.